EN
HI
Summary
As of 14 Nov, 2026, Pharmaids Pharmaceuticals stock price is ₹29.84. During the trading session, the stock has moved between an intraday low of ₹0.00 and an intraday high of ₹0.00. Over the last 52 weeks, Pharmaids Pharmaceuticals has traded between ₹25.60 and ₹66.00.
The stock has recorded a trading volume of 0 shares,. Its Average Traded Price (ATP) is ₹0.00, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 0 @ ₹29.84.
Pharmaids Pharmaceuticals has an upper circuit limit of ₹35.80 and a lower circuit limit of ₹23.88. The total value traded stands at ₹0.00, and the delivery percentage for the day is 0%.
The stock is currently traded with a market lot size of 1. Pharmaids Pharmaceuticals also offers a dividend yield of 0%.
Pharmaids Pharmaceuticals Share Price Chart
Pharmaids Pharmaceuticals Share Key Metrics
Volume
0.00
Market Cap
109.65 CR
LTQ@LTP
0@29.84
ATP
0
Var Margin
25 %
Circuit Range
23.88-35.8
Delivery %
0 %
Value
0.00
ASM/GSM
No
Market Lot
1
Pharmaids Pharmaceuticals Fundamentals
P/E Ratio
0
P/B Ratio
2.12
Div. Yield
0
Sector P/E
41.35
Sector P/B
3.85
Sec. Div. Yield
0.53
Pharmaids Pharmaceuticals Resistance and Support
Pivot 29.6
Resistance
First Resistance
30.2
Second Resistance
30.57
Third Resistance
31.17
Support
First Support
29.23
Second Support
28.63
Third Support
28.26
Pharmaids Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Nov 13 2026 | 30.23 | 28.5 | -4.49% | 30.23 | 28.1 |
| Thu Nov 12 2026 | 29.3 | 29.84 | 2.30% | 29.96 | 29 |
| Wed Nov 11 2026 | 31.5 | 29.17 | -2.77% | 31.5 | 28.56 |
Pharmaids Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-11 | Quarterly Results |
| 2026-08-12 | Quarterly Results |
| 2026-05-29 | Audited Results |
| 2026-02-12 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
| 2025-05-23 | Audited Results |
| 2025-02-12 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
Pharmaids Pharmaceuticals News
Pharmaids Pharmaceuticals Ltd - 524572 - Board Meeting Outcome for Outcome Of The Board Meeting
Pharmaids Pharmaceuticals reported its Q2 FY27 financial results with cons. revenue at ₹4.34 crores, a 50% YoY decline. The company posted a net loss of ₹1.81 crores, an improvement from the ₹3.23 crore loss in Q2 FY26.
Nov 11 2026 19:23:43
Pharmaids Pharmaceuticals Ltd - 524572 - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended 30Th September 2026.
Pharmaids Pharmaceuticals board of directors is scheduled to meet on 11 November 2026 for financial results.
Nov 05 2026 17:45:13
Pharmaids Pharmaceuticals Management
| Name | Position |
|---|---|
| Prasanna Subramanya Bhat | Company Secretary & Compliance Officer |
| Shankarappa Nagaraja Vinaya Babu | Vice Chairman |
Pharmaids Pharmaceuticals Similar Stocks
Star Imaging and Path Lab Ltd.
68.12
0.00 (0.00%)
Alpa Laboratories Ltd.
55.56
0.00 (0.00%)
Mercury Laboratories Ltd.
750.40
0.00 (0.00%)
Bharat Immunologicals & Biologicals Corporation Ltd.
9.02
0.00 (0.00%)
Everest Organics Ltd.
241.25
0.00 (0.00%)
Cian Healthcare Ltd.
39.19
0.00 (0.00%)
Concord Drugs Ltd.
72.95
0.00 (0.00%)
Godavari Drugs Ltd.
109.00
-8.45 (7.19%)
Pharmaids Pharmaceuticals FAQs
The Buying Price of Pharmaids Pharmaceuticals share is 29.84 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Pharmaids Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Pharmaids Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Pharmaids Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Pharmaids Pharmaceuticals shares is 2.12. Useful to assess the stock's value relative to its book value.
To assess Pharmaids Pharmaceuticals’s valuation compare Sector P/E, P/B which are 41.35 & 3.85 with sector averages, along with growth rates and financial metrics.
The Market Cap of Pharmaids Pharmaceuticals is 109.65 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Pharmaids Pharmaceuticals share price is 66.00 & 25.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Pharmaids Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in PHARMAID
